Rapt Therapeutics Inc (RAPT)

Jan 29, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Given Average Recommendation of “Hold” by Brokerages - Defense World

Jan 29, 2025

Jan 28, 2025

Form 424B3 RAPT Therapeutics, Inc. - StreetInsider.com

Jan 28, 2025

Jan 28, 2025

SEC Form 424B3 filed by RAPT Therapeutics Inc. - Quantisnow

Jan 28, 2025

Jan 26, 2025

RAPT Therapeutics shares tumble by 48% after zelnecirnon programme cull - MSN

Jan 26, 2025

Jan 25, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Stake Boosted by Barclays PLC - Defense World

Jan 25, 2025

Jan 14, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Shares Sold by Jane Street Group LLC - Defense World

Jan 14, 2025

Jan 13, 2025

RAPT Therapeutics Plans Phase 2b Trials for RPT904 - TipRanks

Jan 13, 2025

Jan 10, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Shares Purchased by Barclays PLC - Defense World

Jan 10, 2025

Jan 09, 2025

RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 09, 2025

Jan 08, 2025

RAPT Therapeutics appoints new board chair By Investing.com - Investing.com Nigeria

Jan 08, 2025

Jan 06, 2025

RAPT Therapeutics appoints new board chair - Investing.com

Jan 06, 2025

Jan 06, 2025

RAPT Therapeutics, Inc. Announces Board Changes - Marketscreener.com

Jan 06, 2025

Jan 06, 2025

RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company's Board of Directors - The Manila Times

Jan 06, 2025

Jan 06, 2025

RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company’s Board of Directors - Yahoo Finance

Jan 06, 2025

Jan 04, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives $9.56 Average Target Price from Brokerages - MarketBeat

Jan 04, 2025

Jan 04, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives Average Rating of “Hold” from Analysts - Defense World

Jan 04, 2025

Jan 03, 2025

Deal Watch: Regeneron Quietly Acquires UK Ophthalmology Firm Oxular - News & Insights

Jan 03, 2025

Dec 30, 2024

Short Interest in RAPT Therapeutics, Inc. (NASDAQ:RAPT) Grows By 25.5% - MarketBeat

Dec 30, 2024

Dec 28, 2024

Notable analyst calls this week: FREYR Battery, Apple and ServiceNow among top picks - Seeking Alpha

Dec 28, 2024

Dec 27, 2024

Rapt Therapeutics upgraded to Buy from Neutral at H.C. Wainwright - Yahoo Finance

Dec 27, 2024

Dec 27, 2024

RAPT Therapeutics (NASDAQ:RAPT) Upgraded by HC Wainwright to Buy Rating - Defense World

Dec 27, 2024

Dec 26, 2024

RAPT rockets 180% on licensing deal, $150M private placement (update) - MSN

Dec 26, 2024

Dec 26, 2024

RAPT Therapeutics Shares Surge After HC Wainwright Upgrade - Marketscreener.com

Dec 26, 2024

Dec 26, 2024

HC Wainwright & Co. Upgrades RAPT Therapeutics (RAPT) - MSN

Dec 26, 2024

Dec 26, 2024

RAPT upgraded at H.C. Wainwright on China licensing deal - MSN

Dec 26, 2024

Dec 26, 2024

RAPT stock upgraded at H.C. Wainwright (RAPT:NASDAQ) - Seeking Alpha

Dec 26, 2024

Dec 26, 2024

RAPT Therapeutics (NASDAQ:RAPT) Upgraded by HC Wainwright to "Buy" Rating - MarketBeat

Dec 26, 2024

Dec 26, 2024

This Progressive Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday - Benzinga

Dec 26, 2024

Dec 25, 2024

RAPT Therapeutics Announces License Agreement and Private Placement - Defense World

Dec 25, 2024

Dec 24, 2024

RAPT Therapeutics and Shanghai Jemincare sign anti-IgE antibody agreement - Yahoo Finance

Dec 24, 2024

Dec 23, 2024

RAPT Therapeutics soars as it looks to raise $150M in private placement - MSN

Dec 23, 2024

Dec 23, 2024

RAPT Therapeutics sees 113% spike on allergy med licensing deal & private placement - Mugglehead

Dec 23, 2024

Dec 23, 2024

RAPT Therapeutics, Inc. announced that it expects to receive $149.976555 million in funding from a group of investors - Marketscreener.com

Dec 23, 2024

Dec 23, 2024

RAPT Therapeutics stock rises following licensing deal with Jemincare By Investing.com - Investing.com Nigeria

Dec 23, 2024

Dec 23, 2024

RAPT Therapeutics stock rises following licensing deal with Jemincare - Investing.com

Dec 23, 2024

Dec 23, 2024

Peninsula drugmaker lands $150 million, food allergy drug to fill pipeline holeSan Francisco Business Times - The Business Journals

Dec 23, 2024

Dec 23, 2024

Why RAPT Therapeutics Stock Gained Over 100% On Monday? - Yahoo Finance

Dec 23, 2024

Dec 23, 2024

US Stocks Mixed, Dow Tumbles 150 Points - Benzinga

Dec 23, 2024

Dec 23, 2024

Stock market today: iLearningEngines plunges by 60.44% while Reliance Global Group surged by 231.67% in early trading session - Business Upturn

Dec 23, 2024

Dec 23, 2024

RAPT Therapeutics secures rights to new allergy antibody - Investing.com

Dec 23, 2024

Dec 23, 2024

RAPT Therapeutics Partners with Jemincare and Secures Funding - TipRanks

Dec 23, 2024

Dec 23, 2024

RAPT Therapeutics prices 100M shares at 85c in private placement - TipRanks

Dec 23, 2024

Dec 23, 2024

RAPT Therapeutics and Shanghai Jemincare Pharmaceutical - GlobeNewswire

Dec 23, 2024

Dec 23, 2024

RAPT Therapeutics Announces $150 Million Private Placement - GlobeNewswire

Dec 23, 2024

Dec 23, 2024

RAPT Therapeutics and Shanghai Jemincare Pharmaceutical Announce Exclusive License Agreement - The Bakersfield Californian

Dec 23, 2024

Dec 23, 2024

RAPT Therapeutics Secures $672.5M Deal for Breakthrough Anti-IgE Antibody with Extended Half-Life - StockTitan

Dec 23, 2024

Dec 20, 2024

Charles Schwab Investment Management Inc. Cuts Stake in RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World

Dec 20, 2024

Dec 15, 2024

Should You Buy RAPT Therapeutics (RAPT) Ahead of Earnings? - MSN

Dec 15, 2024

Dec 13, 2024

RAPT Therapeutics stock plunges to 52-week low of $0.92 - Investing.com India

Dec 13, 2024

Dec 13, 2024

RAPT Therapeutics' SWOT analysis: stock faces challenges amid pipeline setbacks - Investing.com

Dec 13, 2024

Dec 13, 2024

RAPT Therapeutics stock plunges to 52-week low of $0.92 By Investing.com - Investing.com Nigeria

Dec 13, 2024

Dec 06, 2024

RAPT Therapeutics stock plunges to 52-week low of $1 By Investing.com - Investing.com South Africa

Dec 06, 2024

Dec 06, 2024

RAPT Therapeutics stock plunges to 52-week low of $1 - Investing.com

Dec 06, 2024

Nov 28, 2024

HC Wainwright Has Optimistic Outlook of RAPT FY2024 Earnings - Defense World

Nov 28, 2024

Nov 27, 2024

HC Wainwright Reaffirms “Neutral” Rating for RAPT Therapeutics (NASDAQ:RAPT) - Defense World

Nov 27, 2024